Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1973399339', 'doi': 'https://doi.org/10.1016/j.yrtph.2010.09.014', 'title': 'The evaluation of drug rechallenge: The casopitant Phase III program', 'display_name': 'The evaluation of drug rechallenge: The casopitant Phase III program', 'publication_year': 2010, 'publication_date': '2010-10-07', 'ids': {'openalex': 'https://openalex.org/W1973399339', 'doi': 'https://doi.org/10.1016/j.yrtph.2010.09.014', 'mag': '1973399339', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20932869'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.yrtph.2010.09.014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S87719511', 'display_name': 'Regulatory Toxicology and Pharmacology', 'issn_l': '0273-2300', 'issn': ['0273-2300', '1096-0295'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5047156445', 'display_name': 'Christine M. Hunt', 'orcid': 'https://orcid.org/0000-0002-6874-8889'}, 'institutions': [{'id': 'https://openalex.org/I188950975', 'display_name': 'GlaxoSmithKline (United Kingdom)', 'ror': 'https://ror.org/01xsqw823', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I188950975']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Christine M. Hunt', 'raw_affiliation_strings': ['GlaxoSmithKline, RTP, Durham, NC 27709, USA.'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, RTP, Durham, NC 27709, USA.', 'institution_ids': ['https://openalex.org/I188950975']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070120738', 'display_name': 'Julie I. Papay', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I188950975', 'display_name': 'GlaxoSmithKline (United Kingdom)', 'ror': 'https://ror.org/01xsqw823', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I188950975']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Julie I. Papay', 'raw_affiliation_strings': ['GlaxoSmithKline, RTP, Durham, NC 27709, USA.'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, RTP, Durham, NC 27709, USA.', 'institution_ids': ['https://openalex.org/I188950975']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050810929', 'display_name': 'Donna S Rich', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Donna S. Rich', 'raw_affiliation_strings': ['GlaxoSmithKline, Collegeville, PA, 19426, USA.'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Collegeville, PA, 19426, USA.', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029187388', 'display_name': 'Christopher J. Abissi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher J. Abissi', 'raw_affiliation_strings': ['GlaxoSmithKline, Collegeville, PA, 19426, USA.'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Collegeville, PA, 19426, USA.', 'institution_ids': ['https://openalex.org/I4210114143']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5054535845', 'display_name': 'Mark W. Russo', 'orcid': 'https://orcid.org/0000-0002-5403-3989'}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark W. Russo', 'raw_affiliation_strings': ['GlaxoSmithKline, Collegeville, PA, 19426, USA.'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Collegeville, PA, 19426, USA.', 'institution_ids': ['https://openalex.org/I4210114143']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3800, 'currency': 'USD', 'value_usd': 3800, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.723447, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 77, 'max': 79}, 'biblio': {'volume': '58', 'issue': '3', 'first_page': '539', 'last_page': '543'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11465', 'display_name': 'Drug-Induced Hepatotoxicity and Protection', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11465', 'display_name': 'Drug-Induced Hepatotoxicity and Protection', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Pharmacological Effects and Toxicity Studies', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11635', 'display_name': 'Poisoning and overdose treatments', 'score': 0.996, 'subfield': {'id': 'https://openalex.org/subfields/2711', 'display_name': 'Emergency Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ondansetron', 'display_name': 'Ondansetron', 'score': 0.5490079}, {'id': 'https://openalex.org/keywords/aprepitant', 'display_name': 'Aprepitant', 'score': 0.42443296}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.85887575}, {'id': 'https://openalex.org/C2780580376', 'wikidata': 'https://www.wikidata.org/wiki/Q186889', 'display_name': 'Nausea', 'level': 2, 'score': 0.7054827}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.6867969}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.64967215}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.59942126}, {'id': 'https://openalex.org/C2780852908', 'wikidata': 'https://www.wikidata.org/wiki/Q127076', 'display_name': 'Vomiting', 'level': 2, 'score': 0.57268965}, {'id': 'https://openalex.org/C2777170512', 'wikidata': 'https://www.wikidata.org/wiki/Q410011', 'display_name': 'Ondansetron', 'level': 3, 'score': 0.5490079}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5024073}, {'id': 'https://openalex.org/C2776637226', 'wikidata': 'https://www.wikidata.org/wiki/Q6658207', 'display_name': 'Liver injury', 'level': 2, 'score': 0.49589714}, {'id': 'https://openalex.org/C2780401358', 'wikidata': 'https://www.wikidata.org/wiki/Q422252', 'display_name': 'Dexamethasone', 'level': 2, 'score': 0.48062104}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.465215}, {'id': 'https://openalex.org/C2780574406', 'wikidata': 'https://www.wikidata.org/wiki/Q621834', 'display_name': 'Aprepitant', 'level': 4, 'score': 0.42443296}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.37514564}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34524322}, {'id': 'https://openalex.org/C2780884295', 'wikidata': 'https://www.wikidata.org/wiki/Q575136', 'display_name': 'Antiemetic', 'level': 3, 'score': 0.12645832}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.07918915}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000932', 'descriptor_name': 'Antiemetics', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D064729', 'descriptor_name': 'Neurokinin-1 Receptor Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000932', 'descriptor_name': 'Antiemetics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000932', 'descriptor_name': 'Antiemetics', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D017294', 'descriptor_name': 'Ondansetron', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017294', 'descriptor_name': 'Ondansetron', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D017294', 'descriptor_name': 'Ondansetron', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012702', 'descriptor_name': 'Serotonin Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012702', 'descriptor_name': 'Serotonin Antagonists', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012702', 'descriptor_name': 'Serotonin Antagonists', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.yrtph.2010.09.014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S87719511', 'display_name': 'Regulatory Toxicology and Pharmacology', 'issn_l': '0273-2300', 'issn': ['0273-2300', '1096-0295'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20932869', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.89, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W1966268750', 'https://openalex.org/W1974360290', 'https://openalex.org/W1975440270', 'https://openalex.org/W1984400559', 'https://openalex.org/W1985776762', 'https://openalex.org/W1993860399', 'https://openalex.org/W2000837493', 'https://openalex.org/W2003268732', 'https://openalex.org/W2009648599', 'https://openalex.org/W2017783406', 'https://openalex.org/W2036508709', 'https://openalex.org/W2049789320', 'https://openalex.org/W2055128986', 'https://openalex.org/W2056825570', 'https://openalex.org/W2071385801', 'https://openalex.org/W2079198255', 'https://openalex.org/W2086237560', 'https://openalex.org/W2088004099', 'https://openalex.org/W2088366333', 'https://openalex.org/W2099415813', 'https://openalex.org/W2113183888', 'https://openalex.org/W2116955650', 'https://openalex.org/W2122814201', 'https://openalex.org/W2124012426', 'https://openalex.org/W2133570600', 'https://openalex.org/W2157437146', 'https://openalex.org/W2160491292', 'https://openalex.org/W340037880'], 'related_works': ['https://openalex.org/W4250746515', 'https://openalex.org/W4200452880', 'https://openalex.org/W3029783972', 'https://openalex.org/W2745648606', 'https://openalex.org/W2608768624', 'https://openalex.org/W2467515986', 'https://openalex.org/W2096917975', 'https://openalex.org/W2057593650', 'https://openalex.org/W1824703102', 'https://openalex.org/W1520038824'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1973399339', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}], 'updated_date': '2025-01-09T12:26:51.997753', 'created_date': '2016-06-24'}